Healthcare -
Biotechnology - NASDAQ - US
$ 34.68
0.405 %
$ 1.98 B
Market Cap
2.97
P/E
AGIO - COST OF REVENUE
Cost of Revenue AGIO - Agios Pharmaceuticals, Inc.
9.5 M
LAST VALUE
-28.86%
2 YEAR CAGR
46.74%
5 YEAR CAGR
-16.03%
10 YEAR CAGR